3 recent notable approvals of medical AI

Dave Pearson | | Health Exec | Economics
Green Light

Along with AI, this ongoing list includes regulatory clearances of virtual and augmented reality, 3D printing and other emerging technologies targeted for healthcare.

1. DiA Imaging Analysis (Be’er Sheva, Israel, Oct. 29)—FDA 510(k) clearance for AI selection of optimal echocardiogram views. Product: LVivo Seamless

2. IQ-AI (Jersey, Channel Islands, Nov. 4)—FDA 510(k) clearance for software that uses AI to process CT scans for virtual liver biopsy of patients with chronic liver disease. Product: Liver Surface Nodularity/LSN

3. SenseTime (Abu Dhabi, UAI, Nov. 4)—CE certification for AI interpretation of CT scans with suspected lung diseases, including COVID-19. Product: SenseCare-Lung Pro

To see the previous entry in this series, click here.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

300+ groups urge Senate GOP to reject Medicaid cuts
ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs
Hospitals operating margins stand at 4.4%, the highest in over a year
Medicaid and SNAP cuts may eliminate over 1M jobs
How to address cardiologist burnout
CMS approves Medicare coverage for transcatheter tricuspid valve replacement

Around the web

Cardiovascular Business
ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

Radiology Business
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

One product is being pulled from the market, and the other is receiving updated instructions for use.

AI in Healthcare
What federal regulators can learn from the states about AI oversight

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?